Dermalux LED is a UK-based company specializing in innovative light technologies for the medical, aesthetic, and cosmetic markets. Established in 2012, the company has positioned itself as a world-leading and trusted British brand for professional LED Phototherapy. It manufactures the Dermalux systems in the United Kingdom, ensuring quality, safety, and compliance with industry standards as a fully accredited ISO13485 medical device manufacturer.
The Award-Winning systems offered by Dermalux have been designed with breakthrough proprietary LED technology, clinically proven wavelengths, and results-driven protocols. The Dermalux Portfolio consists of four systems, each featuring a unique Tri-Wave technology that delivers Blue 415nm, Red 633nm, and Near Infrared 830nm. These systems offer superior outcomes for standalone treatments such as rejuvenation, acne, fine lines, and pigmentation. Notably, Dermalux systems are Medically CE marked for Acne, Psoriasis*, Wound healing and Musculoskeletal Pain, making them an essential addition to treatment portfolios within the aesthetic industry.
With a focus on non-invasive skincare, Dermalux has established itself as the go-to treatment for improvements in skin health and vitality. It can be used in combination with various other aesthetic treatments, allowing for upselling existing treatments while accelerating client outcomes. The company's commitment to innovation and excellence has contributed to its status as an industry leader in LED Phototherapy.
There is no investment information
No recent news or press coverage available for Dermalux LED.